Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where S. Castelein is active.

Publication


Featured researches published by S. Castelein.


European Psychiatry | 2015

Effects of Aerobic Exercise On Negative Symptoms in Schizophrenia: a Meta-analysis

J.S. Vogel; M. van der Gaag; S. Castelein

Introduction Negative symptoms in patients with schizophrenia are strongly associated to disease burden. Aerobic exercise might be beneficial in treating negative symptoms. Objective The meta-analysis aims to evaluate the effect of aerobic exercise on negative symptoms in schizophrenia. Methods The Cochrane Library, Medline, Embase, PsycINFO and CINAHL were searched from their inception until 16 March 2014. Randomised controlled trials (RCTs) comparing aerobic exercise with other psychosocial interventions in schizophrenia were included if negative symptoms were assessed. The methodological quality of the studies was assessed with the Clinical Trial Assessment Measure (CTAM). Results Nine studies were included (N= 488). Seven out of nine studies had poor methodological quality as measured with the CTAM. The meta-analysis showed a small non-significant treatment effect in favour of exercise interventions (Hedges’ g = -0.310, CI -0.787 0.168) with a power of 75%. The analysis indicates high heterogeneity (Q(8)=37.163 (P 20 sessions (Hedges’ g = 0.640, CI -1.281 0.000, Q(5)=24.214 (P A large significant effect of exercise was found in five studies comparing exercise to TAU (Hedges’ g=-1.370, CI -2.352 -0.389, Q(4)=29.278 (P Conclusions This meta-analysis demonstrated a significant effect of aerobic exercise on negative symptoms in schizophrenia compared to TAU, but no effect compared to any other (active) control condition. The quality of the included studies was low.


European Psychiatry | 2015

Suicide Revisited: Significant Reduction of Suicide Rate over the Last Two Decades – a Replication Study of a Dutch Incidence Cohort with Recent Onset Psychosis.

S. Castelein; Edith J. Liemburg; J.S. De Lange; F. D. van Es; Els Visser; André Aleman; Richard Bruggeman

Introduction Suicide remains the leading cause of premature death in patients with psychotic disorders. The lifetime suicide risk for schizophrenia is approximately 10%. Objectives This study aims to compare the suicide risk over the past decade following recent onset psychosis to findings from the eighties and nineties in the same catchment area and to identify predictors of suicide in the context of the Psychosis Recent Onset Groningen – Survey (PROGR-S). Methods A medical file search was carried out to determine the current status of all patients admitted between 2000 and 2009. The suicide rate was compared with a study executed in 1973-1988 in the same catchment area. Predictors of suicide were investigated using Cox regression. Results The status of 424 of the 614 patients was known in July 2014. Suicide occurred in 2.4% of the patients with psychotic disorders (n=10; mean follow-up 5.6 years); 6 out of 10 suicides took place within two years. Within two decades, the suicide rate dropped from 11% (follow-up 15 years, 8.5% after 5 years) to 2.4%. The Standardized Mortality Rate (SMR) of suicides compared with the general population was 41.6. A higher age was the only significant predictor for suicide. Neuroticism, living situation, disorganized and negative symptoms, and passive coping style showed a trend for significance. A significant reduction in the suicide rate was found for people with psychosis over the past decades. Conclusions A considerable drop in suicide rate was found. Given the high SMR, suicide research should have the highest priority.


European Psychiatry | 2015

Do Schizophrenia Patients Receive the Care They Need? From Routine Outcome Monitoring to Evidence Based Treatment

S. Castelein; Magda Tasma; Marte Swart; Gert Wolters; Richard Bruggeman

Introduction In schizophrenia the life expectancy is significantly lower compared to the general population. To monitor their functioning over the course of the illness, a protocol for routine outcome monitoring (ROM) has been developed in the Netherlands. Objective This study investigated the effectiveness of Routine Outcome Monitoring (ROM) in clinical practice. More specifically, we investigated whether ROM outcomes resulted in treatment in accordance with guidelines for schizophrenia. Methods Out of the ROM database of 2010 (n=1040), a random sample of 100 patients diagnosed with a psychotic disorder was taken. Data from blood tests, a physical examination, interviews, and standardized questionnaires were used. The prevalence of cardiovascular risk factors, psychosocial problems and sexual dysfunctions was calculated. Offered treatment was investigated with the treatment plans of patients. Results The sample consisted of 63 males and 37 females. The average age was 44 and the average duration of illness was 17.7 years. High prevalences of cardiovascular risk factors, psychosocial problems and sexual dysfunctions were found. Cardiovascular risk factors remained untreated in 61% of cases, psychosocial problems remained untreated in 85% of cases and sexual dysfunctions were not treated at all in our sample. Conclusions High rates of non-treatment were found for cardiovascular risk factors, psychosocial problems and sexual dysfunctions, despite high prevalences as identified with ROM. Thus, ROM outcomes do not result in treatment in accordance with guidelines for the majority of patients. Steps are necessary to bridge the gap between ROM and treatment to ensure this group of severely mentally ill patients receives the best possible treatment.


Archive | 2012

Multidisciplinaire richtlijn schizofrenie

A. van Alphen; M. Ammeraal; C. Blanke; Nynke Boonstra; H. Boumans; R. Bruggeman; S. Castelein; F.L. Dekker; Danielle Van Duin; W. van Ewijk; M. van der Gaag; R. van Gool; R. van Haas; C. Henquet; M. Hermens; T. Ketelaars; M.J. Krans; M. Lansen; R. Lochy; Anton J. M. Loonen; P.D. Meesters; B. van Meijel; G. Miltenburg; M.J.T. Oud; C.F. de Pater; A. Peterse; J. van der Plas; D. Rammers; I.M.F. Rentenaar; G.W. van Santen


Schizophrenia Research | 2003

Sexual dysfunctions and prolactin levels in patients using classical or modern antipsychotics

Rikus Knegtering; S. Castelein; J Linde; J Bous; Richard Bruggeman; Rj Bosch


Schizophrenia Research | 2008

46 – The effectiveness of minimally guided peer support groups for people suffering from psychosis: A randomized controlled trial

S. Castelein; Richard Bruggeman; J. T. van Busschbach; M. van der Gaag; A. D. Stant; Durk Wiersma


Schizophrenia Research | 2001

Sexual dysfunctions in patients using risperidone or olanzapine: A randomised trial

Rikus Knegtering; C Blijd; Durk Wiersma; Richard Bruggeman; van den Robert Bosch; S. Castelein


Tijdschrift voor psychiatrie | 2017

Red ROM als kwaliteitsinstrument

K. de Jong; B.G. Tiemens; M.J.P.M. Verbraak; Aartjan T.F. Beekman; Claudi Bockting; Theo Bouman; S. Castelein; R. van Dyck; Paul M. G. Emmelkamp; C.M. van der Feltz-Cornelis; M. van der Gaag; M.J.H. Huibers; G.J.M. Hutschemaekers; A. de Keijser; G.P.J. Keijsers; B.W. Koekkoek; C.W. Korrelboom; A. van Minnen; P. van Oppen; S.C.C. Oudejans; R.C. Oude Voshaar; Gerard M. Schippers; H.A. Scholing; J. Spijker; P. Spinhoven; A. van Straten; R.J.J.M. Vermeiren; F.G. Zitman


Psychological Medicine | 2016

Letter to the Editor: Should we focus on quality or quantity in meta-analyses?

B. van Oosterhout; Filip Smit; Lydia Krabbendam; S. Castelein; A.B.P. Staring; M. van der Gaag


Tijdschrift voor psychiatrie | 2013

Richtlijn schizofrenie 2012: basiszorg op het gebied van psychosociale interventies en verpleegkundige zorg.

S. Castelein; B. van Meijel; M. van der Gaag

Collaboration


Dive into the S. Castelein's collaboration.

Top Co-Authors

Avatar

Richard Bruggeman

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Durk Wiersma

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

A. D. Stant

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

J. T. van Busschbach

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar

Diederik S. Wiersma

European Laboratory for Non-Linear Spectroscopy

View shared research outputs
Top Co-Authors

Avatar

A. van Minnen

Radboud University Nijmegen

View shared research outputs
Researchain Logo
Decentralizing Knowledge